These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30031143)

  • 1. Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.
    Feng Z; Rao AD; Cheng Z; Shin EJ; Moore J; Su L; Kim SH; Wong J; Narang A; Herman JM; McNutt T; Li D; Ding K
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):651-659. PubMed ID: 30031143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer.
    Rao AD; Feng Z; Shin EJ; He J; Waters KM; Coquia S; DeJong R; Rosati LM; Su L; Li D; Jackson J; Clark S; Schultz J; Hutchings D; Kim SH; Hruban RH; DeWeese TL; Wong J; Narang A; Herman JM; Ding K
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1111-1120. PubMed ID: 28943075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
    Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
    Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement.
    Hooshangnejad H; Han-Oh S; Shin EJ; Narang A; Rao AD; Lee J; McNutt T; Hu C; Wong J; Ding K
    Med Phys; 2022 Jul; 49(7):4794-4803. PubMed ID: 35394064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a rectal spacer with prostate SABR-first UK experience.
    King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
    Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
    Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
    Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
    Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
    Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
    Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
    Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
    Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT.
    Magallon-Baro A; Granton PV; Milder MTW; Loi M; Zolnay AG; Nuyttens JJ; Hoogeman MS
    Radiother Oncol; 2019 Dec; 141():116-122. PubMed ID: 31606227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FEMOSSA: Patient-specific finite element simulation of the prostate-rectum spacer placement, a predictive model for prostate cancer radiotherapy.
    Hooshangnejad H; Youssefian S; Guest JK; Ding K
    Med Phys; 2021 Jul; 48(7):3438-3452. PubMed ID: 34021606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer.
    Taniguchi CM; Murphy JD; Eclov N; Atwood TF; Kielar KN; Christman-Skieller C; Mok E; Xing L; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1090-5. PubMed ID: 23273994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer.
    Brenneman RJ; Goddu SM; Andruska N; Roy A; Bosch WR; Fischer-Valuck B; Efstathiou JA; Gay HA; Michalski JM; Baumann BC
    Pract Radiat Oncol; 2022; 12(2):e117-e122. PubMed ID: 34695615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
    Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
    J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting liver SBRT eligibility and plan quality for VMAT and 4π plans.
    Tran A; Woods K; Nguyen D; Yu VY; Niu T; Cao M; Lee P; Sheng K
    Radiat Oncol; 2017 Apr; 12(1):70. PubMed ID: 28438215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.